OneHealthDrugs
COST (European Cooperation in Science and Technology)

Prof. Alfonso T. García-Sosa, PhD
Associate Professor, Molecular Technology
Institute of Chemistry, University of Tartu 

presented the below reported work:

Recent advances in structural biology and drug discovery | September 18-19, 2023 | Riga | Latvia
https://biodrugconference.osi.lv/

with the work:
“Beyond protein structure prediction” 
Alfonso T. Garcia-Sosa
University of Tartu, Tartu - Estonia

where I acknowledged our COST Action 21111 OneHealthdrugs, as can be seen in the book of abstracts:
https://biodrugconference.osi.lv/abstract-book
 

 

COST
What is COST?

COST (European Cooperation in Science and Technology) is a funding agency for research and innovation networks. The COST ACTIONS help connect research initiatives across Europe and enable scientists to grow their ideas by sharing them with their peers. This boosts their research, career and innovation.

OneHealthdrugs CA21111
Title:

One Health drugs against parasitic vector borne diseases in Europe and beyond

Acronym:

OneHealthdrugs

Start date of the Action:

24/10/2022

End date of the Action:

23/10/2026

CSO approval date:

27/05/2022

Memorandum of Understanding (MoU)

Download file
Contact Points
Chair:

Maria Paola Costi

Vice-Chair:

Anabela Cordeiro da Silva

COST staff

Scientific Officer:
Lucia Forzi
Administrative Officer:
Nathalie Warenghien

Administrative Team

Maria Cristina Notarsanto
Maria Esposito and Laura Leonardi

×